Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

BUY
$135.66 - $197.02 $389,479 - $565,644
2,871 New
2,871 $441,000
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $376,761 - $619,628
3,191 New
3,191 $377,000
Q4 2021

Feb 14, 2022

SELL
$225.82 - $368.51 $198,721 - $324,288
-880 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $195,272 - $426,333
880 New
880 $339,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Meiji Yasuda Life Insurance CO Portfolio

Follow Meiji Yasuda Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meiji Yasuda Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Meiji Yasuda Life Insurance CO with notifications on news.